Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

479
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
479
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

451
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
451
Hypertension I: Introduction01:28

Hypertension I: Introduction

720
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
720
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Hormonal Regulation01:33

Hormonal Regulation

35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

267
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
267

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of the rs7216389 Polymorphism in Orosomucoid-Like 3 (ORMDL3) Gene With Childhood Asthma: A Multicenter Case-Control Study.

Cureus·2026
Same author

Retraction: Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation.

Cureus·2025
Same author

Elucidating the Role of MicroRNAs in Regulating Insulin Signaling Pathways: Implications for the Pathophysiology and Treatment of Type 2 Diabetes.

Cureus·2025
Same author

Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation.

Cureus·2025
Same author

Genetic and Pathological Insights into the rs7216389 Polymorphism in Gasdermin B and Its Association with Childhood Asthma.

Discoveries (Craiova, Romania)·2025
Same author

Complexities of Dengue Fever: Pathogenesis, Clinical Features and Management Strategies.

Discoveries (Craiova, Romania)·2025

Related Experiment Video

Updated: Jan 10, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.2K

Exploring Preeclampsia: A Comprehensive Overview.

Maheen Nasir1, Aimen Binte Asif1, Momnah Waheed1

  • 1CMH Lahore Medical and Dental College, Pakistan.

Discoveries (Craiova, Romania)
|November 25, 2025
PubMed
Summary
This summary is machine-generated.

Preeclampsia is a pregnancy complication marked by high blood pressure and protein in urine after 20 weeks. Biomarkers like sFlt-1 and PlGF aid in early detection and risk assessment for better maternal and fetal outcomes.

Keywords:
biomarkersplacenta.placental growth factorpreeclampsiasoluble fms-like tyrosine kinase

More Related Videos

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.4K
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.2K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.4K
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.2K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Cardiovascular Physiology

Background:

  • Preeclampsia is a significant pregnancy complication characterized by hypertension and proteinuria after 20 weeks gestation.
  • Its complex pathology involves endothelial dysfunction, platelet issues, and an imbalance in angiogenic factors.
  • Current diagnostic methods include blood pressure monitoring, proteinuria assessment, lab tests, and imaging for organ damage.

Purpose of the Study:

  • To review the multifaceted nature of preeclampsia, focusing on its pathology, diagnosis, and management.
  • To highlight the critical role of biomarkers, specifically the sFlt-1/PlGF ratio, in early detection and risk stratification.
  • To provide a comprehensive resource for clinicians on current knowledge and practical approaches to preeclampsia management.

Main Methods:

  • Literature review synthesizing current research on preeclampsia.
  • Analysis of diagnostic criteria and laboratory/imaging techniques.
  • Evaluation of biomarker roles (sFlt-1, PlGF) in disease prediction and stratification.
  • Review of management strategies including antihypertensives, fetal monitoring, and delivery.

Main Results:

  • An imbalance in angiogenic factors, particularly the sFlt-1/PlGF ratio, is key to diagnosing and predicting preeclampsia.
  • Elevated sFlt-1 and reduced PlGF in high-risk pregnancies correlate with increased clinical severity and adverse maternal/fetal outcomes.
  • Management involves antihypertensives, fetal surveillance, and timely delivery based on disease severity.

Conclusions:

  • Preeclampsia remains a significant challenge in pregnancy, requiring a multidisciplinary approach.
  • Biomarkers like sFlt-1 and PlGF are crucial for improving diagnostic accuracy and risk assessment.
  • Continued research into predictive biomarkers and preventative measures is essential for maternal and fetal well-being.